13F-HR filed by GREAT POINT PARTNERS LLC
GREAT POINT PARTNERS LLC filed this 13F-HR for the quarter ended 2013-12-31, filed 2014-02-14, with 28 holding rows worth $141,604,000.
- Accession
- 0000930413-14-000601
- Filer
- CIK 1281446
- Filed
- 2014-02-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q4 2013
A holdings report, 29 entries on the cover page, a total value of $141,604,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $141,604,000 with VALUE read as thousands by filing date, 13F file number 028-11743. The quarter's positions are built on this report. The resolved quarter.
Other managers
- included managerJAY JEFFREY R028-12517
- included managerKROIN DAVID028-13262
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| HYPERION THERAPEUTICS INC | 44915N101 | COM | 811,113 | $16,401,000 | thousands by filing date | |
| PAIN THERAPEUTICS INC | 69562K100 | COM | 2,797,689 | $13,597,000 | thousands by filing date | |
| FURIEX PHARMACEUTICALS | 36106P101 | COM | 319,536 | $13,424,000 | thousands by filing date | |
| SUNSHINE HEART INC | 86782u106 | COM | 915,917 | $8,893,000 | thousands by filing date | |
| AMBIT BIOSCIENCES CORP | 02318X100 | COM | 732,600 | $7,063,000 | thousands by filing date | |
| OCERA THERAPEUTICS INC COM | 67552A108 | COM | 527,797 | $6,856,000 | thousands by filing date | |
| INFINITY PHARMACEUTICALS INC | 45665G303 | COM | 451,100 | $6,230,000 | thousands by filing date | |
| CHEMOCENTRYX INC | 16383L106 | COM | 1,000,000 | $5,790,000 | thousands by filing date | |
| NANOSPHERE INC | 63009F105 | COM | 2,500,000 | $5,725,000 | thousands by filing date | |
| AERIE PHARMACEUTICALS INC | 00771V108 | COM | 308,429 | $5,539,000 | thousands by filing date | |
| AVEO PHARMACEUTICALS INC | 053588109 | COM | 3,000,000 | $5,490,000 | thousands by filing date | |
| VERACYTE INC COM | 92337F107 | Stock | 353,925 | $5,132,000 | thousands by filing date | |
| SOPHIRIS BIO INC F | 83578Q209 | FOREIGN CANADIAN | 1,379,660 | $5,105,000 | thousands by filing date | |
| Cynosure, Inc. | 232577205 | COM | 170,000 | $4,529,000 | thousands by filing date | |
| Alcobra Ltd | M2239P109 | SHS | 250,000 | $4,500,000 | thousands by filing date | |
| HEARTWARE INTL INC | 422368100 | COM | 46,795 | $4,394,000 | thousands by filing date | |
| VOLCANO CORPORATION | 928645100 | COM | 200,000 | $4,370,000 | thousands by filing date | |
| PROTALIX BIOTHERAPEUTICS INC | 74365A101 | COM | 1,000,000 | $3,890,000 | thousands by filing date | |
| HORIZON PHARMA INC | 44047T109 | COM | 500,000 | $3,810,000 | thousands by filing date | |
| CHELSEA THERAPEUTICS INTL LT | 163428105 | COM | 726,800 | $3,223,000 | thousands by filing date | put |
| PSIVIDA CORP | 74440J101 | COM | 500,000 | $1,985,000 | thousands by filing date | |
| AVANIR PHARMACEUTICALS INC | 05348P401 | CL A NEW | 567,000 | $1,905,000 | thousands by filing date | call |
| MEI PHARMA INC | 55279B202 | COM NEW | 157,661 | $1,263,000 | thousands by filing date | |
| COMBIMATRIX CORPORATION | 20009T303 | COM NEW | 369,075 | $849,000 | thousands by filing date | |
| MAST THERAPEUTICS INC | 576314108 | COM | 1,294,934 | $599,000 | thousands by filing date | |
| STREAMLINE HEALTH SOLUTIONS | 86323X106 | COM | 83,969 | $586,000 | thousands by filing date | |
| ROCKWELL MED INC | 774374102 | COM | 40,000 | $418,000 | thousands by filing date | |
| WRIGHT MED GROUP INC | 98235T115 | RIGHT 03/01/2019 | 116,600 | $38,000 | thousands by filing date |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0000930413-14-000601 | this filing | 2014-02-14 | acceptance time not in the bulk data set |